Objectives: To describe the clinical and paraclinical characteristics of chronic otitis media (COM) and evaluate the outcomes of endoscopic type 1 tympanoplasty (myringoplasty).
Methods: A descriptive case series combining retrospective and prospective cohorts with postoperative follow-up was conducted on 30 patients diagnosed with COM who underwent endoscopic type 1 tympanoplasty at Military Hospital 103 from May 2025 to March 2026.
Results: The mean age was 37.8 ± 14.1 years, with the ≤ 30 age group accounting for the highest proportion (40.0%). A history of otorrhea was present in 100% of patients, hearing loss in 80.0%, and tinnitus in 56.7%. All perforations (100%) were located in the pars tensa, with small perforations (< 25%) comprising 60.0%. Conductive hearing loss was observed in 100% of cases, with a median pure-tone average (PTA) of 35.0 [30.0–37.5] dB and a median air-bone gap (ABG) of 21.3 [18.8–25.3] dB. At 3 months postoperatively, the prevalence of hearing loss decreased from 80.0% to 3.3%, and tinnitus from 56.7% to 13.3%. The graft take rate (complete tympanic membrane closure) was 96.7%. The postoperative median ABG was 7.5 [5.9–10.0] dB, representing an improvement of 13.75 dB. The functional success rate (postoperative ABG ≤ 20 dB) reached 100%.
Conclusions: Endoscopic type 1 tympanoplasty yields favorable outcomes, characterized by significant relief of subjective symptoms, a high graft take rate (96.7%), statistically significant hearing improvement (Wilcoxon signed-rank test, p < 0.001), and a 100% functional success rate.